Ica Group Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Ica Group Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $501 - $611	-7 Reduced 0.71%	973 $71,000
Q4 2023 Mar 07, 2024	BUY	$73.27 - $83.09 $71,804 - $81,428	980 New	980 $79,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $7,144 - $8,149	94 Added 13.58%	786 $60,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $16,235 - $18,496	-210 Reduced 23.28%	692 $57,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $148,259 - $212,849	-2,379 Reduced 72.51%	902 $77,000
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $195,350 - $223,140	3,281 New	3,281 $202,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ica Group Wealth Management, LLC with notifications on news.